125 related articles for article (PubMed ID: 37003873)
1. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
[TBL] [Abstract][Full Text] [Related]
2. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
[TBL] [Abstract][Full Text] [Related]
3. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
[TBL] [Abstract][Full Text] [Related]
4. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
Zheng Y; Ju S; Huang R; Zhao J
J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
6. Incidence rate of occult lymph node metastasis in clinical T
Jiang X; Luo C; Peng X; Zhang J; Yang L; Liu LZ; Cui YF; Liu MW; Miao L; Jiang JM; Ren JL; Yang XT; Li M; Zhang L
Respir Res; 2024 May; 25(1):226. PubMed ID: 38811960
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis based on the maximum standard unit value of
Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
[TBL] [Abstract][Full Text] [Related]
8. Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.
Vaghjiani RG; Takahashi Y; Eguchi T; Lu S; Kameda K; Tano Z; Dozier J; Tan KS; Jones DR; Travis WD; Adusumilli PS
J Thorac Oncol; 2020 May; 15(5):792-802. PubMed ID: 32007599
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model.
Ma X; Xia L; Chen J; Wan W; Zhou W
Eur Radiol; 2023 Mar; 33(3):1949-1962. PubMed ID: 36169691
[TBL] [Abstract][Full Text] [Related]
11. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
[No Abstract] [Full Text] [Related]
12. A prediction model for N2 disease in T1 non-small cell lung cancer.
Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
[TBL] [Abstract][Full Text] [Related]
13. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
[TBL] [Abstract][Full Text] [Related]
14. Nomogram for the preoperative prediction of Ki-67 expression and prognosis in stage IA lung adenocarcinoma based on clinical and multi-slice spiral computed tomography features.
Li Z; Liu H; Wang M; Wang X; Pan D; Ma A; Chen Y
BMC Med Imaging; 2024 Jun; 24(1):143. PubMed ID: 38867154
[TBL] [Abstract][Full Text] [Related]
15. A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer.
Zang RC; Qiu B; Gao SG; He J
Chin Med J (Engl); 2017 Feb; 130(4):398-403. PubMed ID: 28218211
[TBL] [Abstract][Full Text] [Related]
16. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
Xue M; Liu J; Li Z; Lu M; Zhang H; Liu W; Tian H
BMC Cancer; 2024 Jan; 24(1):139. PubMed ID: 38287300
[TBL] [Abstract][Full Text] [Related]
17. Predicting occult lymph node metastasis by nomogram in patients with lung adenocarcinoma ≤2 cm.
Wang Z; Wu Y; Wang L; Gong L; Han C; Liang N; Li S
Future Oncol; 2021 Jun; 17(16):2005-2013. PubMed ID: 33784826
[TBL] [Abstract][Full Text] [Related]
18. Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.
Chen M; Yang Y; He C; Chen L; Cheng J
J Xray Sci Technol; 2022; 30(3):599-612. PubMed ID: 35311733
[TBL] [Abstract][Full Text] [Related]
19. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
